Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M674Revenue $M165Net Margin (%)-10.6Z-Score2.2
Enterprise Value $M341EPS $-0.4Operating Margin %-4.8F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-10.4Higher ROA y-yY
Price/Book3.210-y EBITDA Growth Rate %0Quick Ratio6.3Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %-24.3Current Ratio6.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-6.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-9.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.9ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 14.54-113%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 14.54-172%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 14.54-74%New holding75,000
INFIJean-Marie Eveillard 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 14.5412%Sold Out0
INFIJean-Marie Eveillard 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 14.5445%Reduce -54.94%180,000
INFIJean-Marie Eveillard 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 14.5446%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 14.5455%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 14.5458%Reduce -63.91%7,415
INFIJean-Marie Eveillard 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 14.5458%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 14.5462%Reduce -25.39%20,545
INFIJean-Marie Eveillard 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 14.5462%Add 29.72%365,123
INFIJean-Marie Eveillard 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 14.5455%Add 566.95%281,460
INFIJean-Marie Eveillard 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 14.5459%Add 451.43%42,201
INFIJean-Marie Eveillard 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 14.5452%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 14.5446%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-9.13 view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-11.88 view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-1.96 view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-1.96 view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-10.91 view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$15-3.07 view
EVNIN ANTHONY BDirector 2014-09-30Sell112,451$13.567.23 view
Palombella Vito J.Chief Scientific Officer 2014-09-03Sell9,472$15.39-5.52 view
Palombella Vito J.Chief Scientific Officer 2014-07-01Sell879$12.8712.98 view
Palombella Vito J.Chief Scientific Officer 2014-02-25Sell4,736$15-3.07 view

Press Releases about INFI :

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
own Mar 02 2015 
comment on INFI Mar 02 2013 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 


More From Other Websites
The Mariah Carey Business Model Apr 22 2015
Infinity Announces the Date of Its First Quarter 2015 Financial Results Conference Call and Webcast Apr 22 2015
Infinity Announces the Date of Its First Quarter 2015 Financial Results Conference Call and Webcast Apr 22 2015
Infinity Reports Preclinical Data for Duvelisib in Combination with Venetoclax at the 2015 American... Apr 20 2015
Infinity Reports Preclinical Data for Duvelisib in Combination with Venetoclax at the 2015 American... Apr 20 2015
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel Apr 14 2015
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel Apr 14 2015
Here are 10 local biotechs investing heavily in their future Apr 10 2015
Boston Business Journal announces 2015 Women to Watch in Science and Technology honorees Apr 02 2015
Infinity Pharmaceuticals Exercises Duvelisib Royalty Option - Analyst Blog Apr 01 2015
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 31 2015
Infinity Exercises Option to Buy Out All Future Royalty Obligations to Takeda for Duvelisib Sales in... Mar 31 2015
Infinity Exercises Option to Buy Out All Future Royalty Obligations to Takeda for Duvelisib Sales in... Mar 31 2015
Why Infinity Pharmaceuticals (INFI) Could Be Positioned for a Surge? - Tale of the Tape Mar 12 2015
Infinity Provides Company Update and Reports Full-Year 2014 Financial Results Mar 10 2015
INFINITY PHARMACEUTICALS, INC. Financials Mar 03 2015
4 Biotechs Expected to See Huge Buying on PowerShares Rebalance Mar 03 2015
Infinity reports 4Q loss Feb 24 2015
Infinity reports 4Q loss Feb 24 2015
Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today Feb 24 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK